← Signal Board

10x Genomics Class A company information

10X 지노믹스NASDAQ:TXG · Nasdaq · Healthcare
$93.50+5.34%
2026-10-02 close

10x Genomics Class A's company information is shown as of 2026-10-02. It is a security listed on Nasdaq, ticker TXG. There are 14 published related companies.

About this company

10x Genomics Class A last closed at $93.50 (+5.34%) on 2026-10-02. Signals today: 52-week high, MA aligned. Listed on Nasdaq.

2 gurus reporting 13F holdings — Bridgewater (founded by Ray Dalio), Stanley Druckenmiller

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F is quarterly and may be filed up to 45 days later.

Curated gurus reporting this holding

A curated subset of well-known investors — not the full institutional ownership.

Suppliers, competitors and related stocks

  • IlluminaCompetitor

    싱글셀/유전체 분석 인접 영역에서 경쟁

  • Thermo Fisher ScientificCompetitor

    유전체·세포분석 연구장비/소모품에서 경쟁

  • Becton, Dickinson and CompanyCompetitor

    세포분석·실험실 솔루션 영역의 경쟁사

  • Standard BioToolsCompetitor

    멀티오믹스·세포 분석 플랫폼 경쟁

  • Bio-Rad LaboratoriesCompetitor

    분자진단·세포분석/실험실 장비 경쟁

  • Mission BioCompetitor

    싱글셀 멀티오믹스에서 경쟁

  • 10x Genomics 고객(대학/연구기관)Customer

    주요 매출처는 학계·연구기관 중심

  • NovartisCustomer

    제약 R&D에서 싱글셀 분석 수요가 큼

  • RocheCustomer

    바이오파마 연구개발 고객

  • PfizerCustomer

    신약개발 연구에서 사용

  • Merck & Co.Customer

    제약 R&D 및 번역연구 수요

  • AmgenCustomer

    세포·유전체 기반 연구 고객

  • Broad InstituteCustomer

    싱글셀/유전체 연구의 대표적 대형 연구기관 고객

  • IlluminaSupplier

    다운스트림 시퀀싱 생태계와 기술적 연계가 큼

Major stocks in the same sector

2026-10-03 dataset

📦 ETFs holding this stock

by weight · top-10 constituents basis

Passive money holding this stock ≈ $264M(lower bound — top-10 basis, not a forecast)

Factual holdings info from daily disclosures — not a recommendation.

Look up another stock →

10x Genomics Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q